250MG TBL FLM 40
Announcement of launch, break or close-out of marketing of a medicinal product
|Type of announcement||Effective date||Alternate medicines ?||Reason for interruption/cessation of marketing||Estimated renewal date|
|Cessation of marketing||14.08.2022||
|Interruption of marketing||19.01.2022||
|Placing on the market||20.10.2021|
All reports are available in the Overview.